Development of a serological assay based on a synthetic peptide selected from the VP0 capsid protein for detection of human parechoviruses

Journal of Clinical Microbiology

Volumn 45, Issue 6, 2007, Pages 2037-2039

  Abed, Yacine ^a,d   Wolf, Dana ^b   Dagan, Ron ^c   Boivin, Guy ^a,d  

^a LAVAL UNIVERSITY   (Canada)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; PROTEIN VP0; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PARECHOVIRUS; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROPREVALENCE; VIRUS CAPSID; VIRUS DETECTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CAPSID PROTEINS; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFANT; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PARECHOVIRUS; PEPTIDES; PICORNAVIRIDAE INFECTIONS; SEROEPIDEMIOLOGIC STUDIES;

MIRIDAE;

EID: 34250653628     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02432-06     Document Type: Article

References (13)

1. Abed, Y., and G. Boivin. 2006. Human parechovirus infections in Canada. Emerg. Infect. Dis. 12:969-975.
2. Al-Sunaidi, M., C. H. Williams, P. J. Hughes, D. P. Schnurr, and G. Stanway. 2007. Analysis of a new human parechovirus allows the definition of parechovirus types and the identification of RNA structural domains. J. Virol. 81:1013-1021.
3. Benschop, K. S. M., J. Schinkel, R. P. Minnaar, D. Pajkrt, L. Spanjerberg, H. C. Kraakman, B. Berghout, H. L. Zaajer, M. G. H. M. Beld, and K. C. Wolthers. 2006. Human parechovirus infections in Dutch children and the association between serotype and disease severity. Clin. Infect. Dis. 42:204-210.
4. Boivin, G., Y. Abed, and F. D. Boucher. 2005. Human parechovirus-3 and neonatal infections. Emerg. Infect. Dis. 11:103-105.
5. Figueroa, J. P., D. Ashley, D. King, and B. Hull. 1989. An outbreak of acute flaccid paralysis in Jamaica associated with echovirus type 22. J. Med. Virol. 29:315-319.
6. Ito, M., T. Yamashita, H. Tsuzuki, N. Takeda, and K. Sakae. 2004. Isolation and identification of a novel human parechovirus. J. Gen. Virol. 85:391-398.
7. Joki-Korpela, P., and T. Hyypia. 1998. Diagnosis and epidemiology of echovirus 22 infections. Clin. Infect. Dis. 26:129-136.
8. Joki-Korpela, P., M. Roivainen, T. Poyry, and T. Hyypia. 2000. Antigenic properties of human parechovirus 1. J. Gen. Virol. 81:1709-1718.
9. Joki-Korpela, P., and T. Hyypia. 2001. Parechoviruses, a novel group of human picornaviruses. Ann. Med. 33:466-471.
10. Koskiniemi, M., R. Paeteau, and K. Linnavuori. 1989. Severe encephalitis associated with disseminated echovirus 22 infection. Scand. J. Infect. Dis. 21:463-466.
11. Niklasson, B., L. Kinnunen, B. Hornfeldt, J. Horling, C. Benemar, K. O. Hedlund, L. Matskova, T. Hyypia, and G. Winberg. 1999. A new picornavirus isolated from bank voles (Clethriomys glareolus). Virology 255:86-93.
12. Stanway, G., and T. Hyypiä. 1999. Parechoviruses. J. Virol. 73:5249-5254.
13. Stanway, G., P. Joki-Korpela, and T. Hyypiä. 2000. Human parechoviruses - biology and clinical significance. Rev. Med. Virol. 10:57-69.